Drug profile · INN
simethicone-cellulose
SONORX
simethicone-cellulose (SONORX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — simethicone-cellulose
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
simethicone-cellulose (SONORX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is simethicone-cellulose?
simethicone-cellulose (SONORX) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for simethicone-cellulose?
SONORX is a marketed brand name for simethicone-cellulose. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of simethicone-cellulose?
simethicone-cellulose has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.